Search

everythinglearnresearchcommunity

for

Search:↓

SEM/EDX can analyze hair elements but struggles with trace elements, limiting its forensic use.

Biopsy is crucial for accurately diagnosing EPDS to avoid mistaking it for SCC.

EPDS and MS might share an immune-related cause.

SII is a useful and affordable tool to assess and monitor alopecia areata.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

The method successfully visualizes iodine in biological tissues.

Biopsy is crucial to accurately distinguish Erosive Pustular Dermatosis of the Scalp from Squamous Cell Carcinoma.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

SLE is likely one disease with various symptoms, not multiple distinct diseases.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

New tests detect finasteride and dutasteride in urine quickly and easily.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Antimicrobial therapy can help manage Folliculitis Decalvans.